AU2013204801A1 - Composition and method for management of diabetes or pre-diabetes - Google Patents

Composition and method for management of diabetes or pre-diabetes

Info

Publication number
AU2013204801A1
AU2013204801A1 AU2013204801A AU2013204801A AU2013204801A1 AU 2013204801 A1 AU2013204801 A1 AU 2013204801A1 AU 2013204801 A AU2013204801 A AU 2013204801A AU 2013204801 A AU2013204801 A AU 2013204801A AU 2013204801 A1 AU2013204801 A1 AU 2013204801A1
Authority
AU
Australia
Prior art keywords
diabetes
management
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2013204801A
Other versions
AU2013204801B2 (en
Inventor
Janena Frances BEST
Peter Richard Wynter BEST
Christopher Walter LICHTI
Gottfried Lichti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OMNIBLEND INNOVATION Pty Ltd
Original Assignee
OMNIBLEND INNOVATION Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OMNIBLEND INNOVATION Pty Ltd filed Critical OMNIBLEND INNOVATION Pty Ltd
Priority claimed from AU2013204801A external-priority patent/AU2013204801B2/en
Priority to AU2013204801A priority Critical patent/AU2013204801B2/en
Priority to CN201380038152.4A priority patent/CN105578903B/en
Priority to CA2874034A priority patent/CA2874034C/en
Priority to US14/403,092 priority patent/US9675553B2/en
Priority to PCT/AU2013/000537 priority patent/WO2013173874A2/en
Priority to NZ701302A priority patent/NZ701302A/en
Priority to KR1020147035153A priority patent/KR102115863B1/en
Priority to EP13794201.7A priority patent/EP2852298B1/en
Priority to JP2015512970A priority patent/JP6414897B2/en
Publication of AU2013204801A1 publication Critical patent/AU2013204801A1/en
Publication of AU2013204801B2 publication Critical patent/AU2013204801B2/en
Application granted granted Critical
Priority to ZA2014/08480A priority patent/ZA201408480B/en
Priority to IL235855A priority patent/IL235855A/en
Priority to HK15109411.5A priority patent/HK1208783A1/en
Priority to US15/464,144 priority patent/US9775801B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013204801A 2012-05-23 2013-04-12 Composition and method for management of diabetes or pre-diabetes Active AU2013204801B2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
AU2013204801A AU2013204801B2 (en) 2012-05-23 2013-04-12 Composition and method for management of diabetes or pre-diabetes
EP13794201.7A EP2852298B1 (en) 2012-05-23 2013-05-22 Composition for management of diabetes or pre-diabetes
JP2015512970A JP6414897B2 (en) 2012-05-23 2013-05-22 Compositions and methods for the management of diabetes or pre-diabetes
CA2874034A CA2874034C (en) 2012-05-23 2013-05-22 Composition and method for management of diabetes or pre-diabetes
US14/403,092 US9675553B2 (en) 2012-05-23 2013-05-22 Composition and method for management of diabetes or pre-diabetes
PCT/AU2013/000537 WO2013173874A2 (en) 2012-05-23 2013-05-22 Composition and method for management of diabetes or pre-diabetes
NZ701302A NZ701302A (en) 2012-05-23 2013-05-22 Composition and method for management of diabetes or pre-diabetes
KR1020147035153A KR102115863B1 (en) 2012-05-23 2013-05-22 Composition and method for management of diabetes or pre-diabetes
CN201380038152.4A CN105578903B (en) 2012-05-23 2013-05-22 Composition for controlling diabetes or prediabetes and method
ZA2014/08480A ZA201408480B (en) 2012-05-23 2014-11-18 Composition and method for management of diabetes or pre-diabetes
IL235855A IL235855A (en) 2012-05-23 2014-11-23 Drink for moderating blood glucose levels in diabetic or pre-diabetic subjects
HK15109411.5A HK1208783A1 (en) 2012-05-23 2015-09-24 Composition and method for management of diabetes or pre-diabetes
US15/464,144 US9775801B2 (en) 2012-05-23 2017-03-20 Composition and method for management of diabetes or pre-diabetes

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261650769P 2012-05-23 2012-05-23
US61/650,769 2012-05-23
AU2012904029 2012-09-14
AU2012904029A AU2012904029A0 (en) 2012-09-14 Composition and method for management of diabetes or pre-diabetes
AU2013204801A AU2013204801B2 (en) 2012-05-23 2013-04-12 Composition and method for management of diabetes or pre-diabetes

Publications (2)

Publication Number Publication Date
AU2013204801A1 true AU2013204801A1 (en) 2013-12-12
AU2013204801B2 AU2013204801B2 (en) 2014-11-06

Family

ID=49624403

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013204801A Active AU2013204801B2 (en) 2012-05-23 2013-04-12 Composition and method for management of diabetes or pre-diabetes

Country Status (12)

Country Link
US (2) US9675553B2 (en)
EP (1) EP2852298B1 (en)
JP (1) JP6414897B2 (en)
KR (1) KR102115863B1 (en)
CN (1) CN105578903B (en)
AU (1) AU2013204801B2 (en)
CA (1) CA2874034C (en)
HK (1) HK1208783A1 (en)
IL (1) IL235855A (en)
NZ (1) NZ701302A (en)
WO (1) WO2013173874A2 (en)
ZA (1) ZA201408480B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160287515A1 (en) * 2013-11-19 2016-10-06 Omniblend Innovation Pty Ltd Regimen and method for treatment of type 2 diabetes
AU2016250911A1 (en) * 2015-04-23 2017-11-09 Omniblend Innovation Pty Ltd Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile
AU2021305336A1 (en) 2020-07-10 2023-03-02 C° Change Surgical Llc Injectable slush feed supply

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT69968A (en) 1978-07-25 1979-08-01 Wellcome Found Pharmaceutical formulation of guar gum
CA1201321A (en) 1981-12-22 1986-03-04 Anne-Marie Dahlen Protein-fruit drink
CA1221575A (en) 1983-10-17 1987-05-12 John A. Colliopoulos Psyllium mucilloid products
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5104676A (en) 1991-06-27 1992-04-14 Abbott Laboratories Weight control product
US5547275A (en) * 1995-08-17 1996-08-20 Dart Industries Inc. Shaker and blender
US5747532A (en) 1995-11-21 1998-05-05 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6139900A (en) * 1998-08-11 2000-10-31 North Carolina State University Method of forming whey protein products
GB9927603D0 (en) 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
GB0213612D0 (en) * 2002-06-13 2002-07-24 Novartis Nutrition Ag Organic compounds
US20040087514A1 (en) 2002-09-06 2004-05-06 Hughes Thomas E Nutritional compositions
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US20060171992A1 (en) 2002-12-20 2006-08-03 Gerhardt Cinderella C Blood glucose regulating composition
US7824706B2 (en) * 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
CN1835762B (en) 2003-06-30 2010-05-12 雀巢技术公司 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
JP2005204943A (en) * 2004-01-22 2005-08-04 Shusuke Nagai Cocktail shaker
GB2432772B (en) * 2005-11-30 2011-06-01 Sis Improvements in and relating to nutritional products
DK1983849T3 (en) 2006-01-20 2013-07-08 Innova Food Ab FOOD COMPOSITION CONTAINING AMINO ACIDS
US7977319B1 (en) 2006-04-03 2011-07-12 Scott David Levine Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
EA200802128A1 (en) 2006-04-12 2009-04-28 ДСМ АйПи АССЕТС Б.В. NEW NUTRITSEVTIKY COMPOSITIONS
US8518469B2 (en) * 2007-06-12 2013-08-27 Kraft Foods Group Brands Llc Powdered beverage composition
DK2268669T3 (en) 2008-03-13 2017-11-20 Immuron Ltd Bovine colostrum containing antibodies to insulin for the treatment of metabolic disorders
CA2676518A1 (en) 2008-08-29 2010-02-28 Kraft Foods Global Brands Llc Whey protein pre-load
KR101785120B1 (en) 2009-04-27 2017-10-12 이뮤론 리미티드 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
RU2589697C2 (en) * 2009-12-18 2016-07-10 Экзодос Лайф Сайенсиз Лимитед Партнершип Methods of producing a stable liquid drugs and compositions thereof

Similar Documents

Publication Publication Date Title
EP3715345B8 (en) Preparation of lfa-1 inhibitor
EP2676220A4 (en) System and method for application attestation
EP2663864B8 (en) Immunodiversity assessment method and its use
HUE038664T2 (en) C6-c18-acylated derivative of hyaluronic acid, method of preparation thereof, nanomicellar composition on its basis, method of preparation thereof and method of preparation stabilized nanomicellar composition, and use thereof
EP2761016A4 (en) Composition of redox-reagents for electrochemical biosensor and biosensor comprising the same
EP2852588B8 (en) Hydantoin derivatives as kv3 inhibitors
EP2887940A4 (en) Inhibitors of crl4 ubiquitin ligase and uses thereof
HK1208783A1 (en) Composition and method for management of diabetes or pre-diabetes
AU2013204801A1 (en) Composition and method for management of diabetes or pre-diabetes
ZA201408065B (en) Compositions and methods for the treatment of diabetes
EP2681287A4 (en) Adhesive patch and method of using the same
AU2012904029A0 (en) Composition and method for management of diabetes or pre-diabetes
EP3067403A4 (en) Sealant composition and preparation method therefor
AU2012905441A0 (en) Composition and method for maintaining/improving cognitive function
AU2012903090A0 (en) Compounds and methods of their use - IV
AU2012901291A0 (en) Method of joint assembly and joint release mechanism
AU2012901799A0 (en) Thermo-Electrochemical Cell and Method of Use
AU2012902167A0 (en) Methods for Assessing Diabetic Conditions and Uses Therefor
AU2012900651A0 (en) Compounds and methods of their use
AU2012900650A0 (en) Compounds and methods of their use
AU2010901721A0 (en) Method and composition
AU2012900986A0 (en) Compounds and Methods - II
AU2012900987A0 (en) Compounds and Methods - I
AU2011903137A0 (en) Compounds and methods of their use - IV
AU2012901543A0 (en) Method and system of selecting an agent